SCHEMBL10101186

SCHEMBL10101186

COc1cc(O)c(CN2CCOCC2)c2c1[C@]1(C)CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]1CS2(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 1/20 0.39
PIK3CA P42336 1/20 0.37
PIK3CG P48736 1/20 0.37
ALOX15 P16050 2/20 0.36
ALOX12 P18054 2/20 0.36
TP53 P04637 2/20 0.35
RXFP1 Q9HBX9 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
CETP P11597 3/20 0.35
MAPT P10636 1/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 2/20 0.34
RCE1 Q9Y256 1/20 0.34
MAPK1 P28482 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP19A1 P11511 1/20 0.34
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101188 0.76 FKBP1A (0.41) TP53MAPTKDM4EALDH1A1MAPK1
SCHEMBL10101153 0.73 PIK3CB (0.42) PIK3CBPIK3CAPIK3CGALOX15ALOX12
SCHEMBL10101169 0.72 PIK3CB (0.41) PIK3CBPIK3CAPIK3CGKDM4EALDH1A1
SCHEMBL10101289 0.72 PIK3CB (0.36) PIK3CBPIK3CAPIK3CGALOX15ALOX12
SCHEMBL10101366 0.72 PIK3CB (0.38) PIK3CBPIK3CAPIK3CGTRPV1ALDH1A1
SCHEMBL10101170 0.71 PIK3CB (0.41) PIK3CBPIK3CAPIK3CGMAPTKDM4E
SCHEMBL10101338 0.70 PIK3CB (0.41) PIK3CBPIK3CAPIK3CGALOX15ALOX12
SCHEMBL10101126 0.70 PIK3CB (0.39) PIK3CBPIK3CAPIK3CGALOX15ALOX12
SCHEMBL10101136 0.70 PIK3CB (0.44) PIK3CBPIK3CAPIK3CGALOX15ALOX12
SCHEMBL10101361 0.69 PIK3CB (0.40) PIK3CBPIK3CAPIK3CGALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101605-B2 SHIP1 modulators and methods related thereto AQUINOX PHARMACEUTICALS INC. (CA) 2012-01-24 US disclosed
US-20110136802-A1 SHIP1 MODULATORS AND METHODS RELATED THERETO AQUINOX PHARMACEUTICALS INC. (CA) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136802-A1 SHIP1 MODULATORS AND METHODS RELATED THERETO PPM1D, PTPRO, PPM1G PIK3CB 98/4885PIK3CA 128/4885PIK3CG 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.